The emerging treatment of the medication represents a major development in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets multiple pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide670301.blogolenta.com/39079792/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment